Literature DB >> 20395936

Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine.

.   

Abstract

The emergence and spread of 2009 pandemic influenza A (H1N1) virus resulted in substantial influenza activity in the United States throughout the summer and fall months of 2009, with activity peaking in late October. Activity declined beginning in November 2009 but continued at lower levels through March 2010. The 2009 H1N1 virus remained the dominant circulating influenza virus throughout the season; <1% of characterized viruses were seasonal influenza A (H1), A (H3), and influenza B viruses. This report summarizes U.S. influenza activity from August 30, 2009, the start of the 2009-10 influenza season, through March 27, 2010, and also reports on the 2010-11 Northern Hemisphere influenza vaccine strain selection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395936

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  42 in total

1.  Influenza A/H1N1/09-10 infections in a NICU during the 2009-2010 H1N1 pandemic.

Authors:  Navin K Vij; Christopher C Stryker; Frank P Esper; Michael R Jacobs; Blanca E Gonzalez
Journal:  Pediatrics       Date:  2011-10-03       Impact factor: 7.124

Review 2.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

3.  Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Authors:  Sharon K Greene; Melisa Rett; Eric S Weintraub; Lingling Li; Ruihua Yin; Anthony A Amato; Doreen T Ho; Sarah I Sheikh; Bruce H Fireman; Matthew F Daley; Edward A Belongia; Steven J Jacobsen; Roger Baxter; Tracy A Lieu; Martin Kulldorff; Claudia Vellozzi; Grace M Lee
Journal:  Am J Epidemiol       Date:  2012-05-11       Impact factor: 4.897

4.  Newly emerging mutations in the matrix genes of the human influenza A(H1N1)pdm09 and A(H3N2) viruses reduce the detection sensitivity of real-time reverse transcription-PCR.

Authors:  Ji-Rong Yang; Chuan-Yi Kuo; Hsiang-Yi Huang; Fu-Ting Wu; Yi-Lung Huang; Chieh-Yu Cheng; Yu-Ting Su; Feng-Yee Chang; Ho-Sheng Wu; Ming-Tsan Liu
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

5.  Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.

Authors:  Silvana Carr; Natalia A Ilyushina; John Franks; Elisabeth E Adderson; Miguela Caniza; Elena A Govorkova; Robert G Webster
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

6.  Emergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic.

Authors:  Maribeth C Lovegrove; Nadine Shehab; Craig M Hales; Kathy Poneleit; Elizabeth Crane; Daniel S Budnitz
Journal:  Public Health Rep       Date:  2011 May-Jun       Impact factor: 2.792

Review 7.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

8.  Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011.

Authors:  Astride Jules; Carlos G Grijalva; Yuwei Zhu; H Keipp Talbot; John V Williams; Katherine A Poehling; Sandra S Chaves; Kathryn M Edwards; William Schaffner; David K Shay; Marie R Griffin
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

9.  Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial.

Authors:  Mary S Hayney; Christopher L Coe; Daniel Muller; Chidi N Obasi; Uba Backonja; Tola Ewers; Bruce Barrett
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

10.  Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.

Authors:  Rafael A Medina; Balaji Manicassamy; Silke Stertz; Christopher W Seibert; Rong Hai; Robert B Belshe; Sharon E Frey; Christopher F Basler; Peter Palese; Adolfo García-Sastre
Journal:  Nat Commun       Date:  2010-06-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.